More tools:Markets·Screener·Research·Chat

Grifois, S.A. (GRFS) Financial Statements

Grifois, S.A.
SIC 2834 · PHARMACEUTICAL PREPARATIONS
FIGI BBG001V1HXJ9
XNAS · usd
7.75▼ 0.05 (-0.64%)
As of 2026-09-08
Valuation
Market Cap
Enterprise Value
Trailing P/E
Price / Sales
EV / Revenue
EV / EBITDA
Financial Highlights
Revenue (TTM)
Net Income (TTM)
EBITDA
Diluted EPS (TTM)
EBITDA Margin
Net Debt
Trading Information
Previous Close7.80
Day's Range7.74 – 7.83
52-Week Range6.96 – 10.23
Volume298.4K
Avg Volume476.2K
Share Statistics
Shares Outstanding
Employees25.2K
ExchangeXNAS
Listed2011-06-02
Share count as of December 31, 2025
Loading Income Statement…
Key questions about Grifois, S.A. (GRFS)
What is Grifois, S.A.'s Market Cap?
Grifois, S.A.'s Market Cap is $5.3B, based on as-reported figures from SEC (XBRL) filings.
What is Grifois, S.A.'s Enterprise Value?
Grifois, S.A.'s Enterprise Value is $6.9B, based on as-reported figures from SEC (XBRL) filings.
What is Grifois, S.A.'s Trailing P/E?
Grifois, S.A.'s Trailing P/E is 9.1×, based on as-reported figures from SEC (XBRL) filings.
What is Grifois, S.A.'s Price / Sales?
Grifois, S.A.'s Price / Sales is 0.6×, based on as-reported figures from SEC (XBRL) filings.
What is Grifois, S.A.'s EV / Revenue?
Grifois, S.A.'s EV / Revenue is 0.8×, based on as-reported figures from SEC (XBRL) filings.
What is Grifois, S.A.'s EV / EBITDA?
Grifois, S.A.'s EV / EBITDA is 3.5×, based on as-reported figures from SEC (XBRL) filings.
What is Grifois, S.A.'s Revenue (TTM)?
Grifois, S.A.'s Revenue (TTM) is $8.8B, based on as-reported figures from SEC (XBRL) filings.
What is Grifois, S.A.'s Net Income (TTM)?
Grifois, S.A.'s Net Income (TTM) is $586.8M, based on as-reported figures from SEC (XBRL) filings.
What is Grifois, S.A.'s EBITDA?
Grifois, S.A.'s EBITDA is $2.0B, based on as-reported figures from SEC (XBRL) filings.
What is Grifois, S.A.'s Diluted EPS (TTM)?
Grifois, S.A.'s Diluted EPS (TTM) is 0.85, based on as-reported figures from SEC (XBRL) filings.
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in millions of USD, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019Dec 31, 2018Dec 31, 2017
Continuing Operations
Net revenue
Cost of sales
Gross Margin
Research and development
Selling, general and administration expenses
Operating Expenses
Other income
Profit of equity accounted investees with similar activity to that of the Group
Operating Result
Finance income
Finance costs
Dividends
Financial cost of sale of trade receivables
Change in fair value of financial instruments
Impairment of financial assets
Exchange differences
Finance result
Profit/(loss) of other equity accounted investees—
Profit before income tax
Income tax expense
Profit after income tax from continuing operations—
Consolidated net profit
Profit attributable to the Parent
Profit attributable to non-controlling interest
Basic earnings per share (Euros)
Diluted earnings per share (Euros)